Insufficient scRNA-seq data for expression of TNFSF18 at single-cell level.
Insufficient scRNA-seq data for expression of TNFSF18 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 91% | 20.51 | 2407 / 2642 | 66% | 4.60 | 465 / 705 |
| lung | 88% | 13.76 | 507 / 578 | 49% | 2.43 | 570 / 1155 |
| esophagus | 87% | 32.49 | 1261 / 1445 | 46% | 2.74 | 85 / 183 |
| thymus | 68% | 9.18 | 444 / 653 | 45% | 1.83 | 271 / 605 |
| intestine | 60% | 6.23 | 581 / 966 | 23% | 0.61 | 121 / 527 |
| stomach | 52% | 4.93 | 185 / 359 | 31% | 0.99 | 89 / 286 |
| breast | 52% | 5.28 | 240 / 459 | 28% | 0.63 | 318 / 1118 |
| pancreas | 29% | 1.78 | 96 / 328 | 51% | 1.51 | 91 / 178 |
| skin | 64% | 14.06 | 1158 / 1809 | 13% | 0.32 | 63 / 472 |
| spleen | 77% | 7.54 | 186 / 241 | 0% | 0 | 0 / 0 |
| kidney | 47% | 5.48 | 42 / 89 | 27% | 0.72 | 246 / 901 |
| adipose | 69% | 7.26 | 831 / 1204 | 0% | 0 | 0 / 0 |
| prostate | 65% | 5.69 | 159 / 245 | 3% | 0.06 | 17 / 502 |
| tonsil | 0% | 0 | 0 / 0 | 64% | 2.73 | 29 / 45 |
| adrenal gland | 47% | 5.45 | 122 / 258 | 14% | 0.33 | 33 / 230 |
| heart | 57% | 4.92 | 487 / 861 | 0% | 0 | 0 / 0 |
| bladder | 33% | 2.95 | 7 / 21 | 19% | 0.59 | 95 / 504 |
| uterus | 22% | 1.42 | 38 / 170 | 19% | 0.82 | 86 / 459 |
| blood vessel | 41% | 4.01 | 545 / 1335 | 0% | 0 | 0 / 0 |
| ovary | 28% | 1.86 | 50 / 180 | 10% | 0.20 | 43 / 430 |
| liver | 25% | 1.59 | 56 / 226 | 12% | 0.22 | 50 / 406 |
| muscle | 27% | 1.38 | 213 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 21% | 0.43 | 6 / 29 |
| peripheral blood | 12% | 0.78 | 110 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
| GO_0007165 | Biological process | signal transduction |
| GO_0042129 | Biological process | regulation of T cell proliferation |
| GO_0045785 | Biological process | positive regulation of cell adhesion |
| GO_0007267 | Biological process | cell-cell signaling |
| GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
| GO_0002250 | Biological process | adaptive immune response |
| GO_0043066 | Biological process | negative regulation of apoptotic process |
| GO_0002687 | Biological process | positive regulation of leukocyte migration |
| GO_0002309 | Biological process | T cell proliferation involved in immune response |
| GO_0033209 | Biological process | tumor necrosis factor-mediated signaling pathway |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0009986 | Cellular component | cell surface |
| GO_0032813 | Molecular function | tumor necrosis factor receptor superfamily binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005102 | Molecular function | signaling receptor binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0005125 | Molecular function | cytokine activity |
| Gene name | TNFSF18 |
| Protein name | Tumor necrosis factor ligand superfamily member 18 (Activation-inducible TNF-related ligand) (AITRL) (Glucocorticoid-induced TNF-related ligand) (hGITRL) |
| Synonyms | AITRL UNQ149/PRO175 TL6 GITRL |
| Description | FUNCTION: Cytokine that binds to TNFRSF18/AITR/GITR. Regulates T-cell responses. Can function as costimulator and lower the threshold for T-cell activation and T-cell proliferation. Important for interactions between activated T-lymphocytes and endothelial cells. Mediates activation of NF-kappa-B. Triggers increased phosphorylation of STAT1 and up-regulates expression of VCAM1 and ICAM1 . Promotes leukocyte adhesion to endothelial cells . Regulates migration of monocytes from the splenic reservoir to sites of inflammation (By similarity). . |
| Accessions | Q9UNG2 ENST00000404377.5 |